Position in CRVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$36,557,808
+$9,084,919 QoQ
Shares Held
2,498,825
-30.0% QoQ
Ownership
2.97%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 81.07258411453383.ToString("F0")%
Shared 0.ToString("F0")%
None 18.92741588546617.ToString("F0")%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. CRVS ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in CRVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,557,808 | 2,498,825 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $27,472,889 | 3,567,908 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,548,940 | 617,224 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,577,620 | 894,405 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,141,805 | 673,524 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,125,896 | 397,364 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,076,422 | 393,262 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $675,952 | 371,403 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $490,141 | 275,361 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $456,992 | 259,655 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $281,057 | 192,506 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $319,763 | 139,635 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $91,144 | 100,159 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $61,713 | 72,605 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $32,199 | 39,317 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $48,853 | 49,348 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $67,012 | 40,862 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $88,869 | 36,876 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $144,924 | 29,943 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $99,120 | 37,124 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $114,738 | 37,253 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $135,077 | 37,943 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $131,311 | 32,746 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $40,914 | 15,042 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $69,461 | 32,920 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||